InsiderClue
← All stocks

Barinthus Biotherapeutics plc.

BRNS Net buying
CIK 0001828185 #4953 in the set updated 22 Sep 2026
Bought (120 mo)
$12.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$461.55K
$0.00 on a plan · $309.22K straight out of an exercise
Sold at will
$152.33K
6 of 15 sales
Net
+$12.14M
+$12.45M against sales at will

By person

13 insiders · 29 transactions
7.1×

William Enright holds 7.1 times base salary in stock. $4.70M of shares against $653.43K in salary for 2025.

Salary from the company's own proxy. The shares are what William Enright last reported holding, valued at $2.44, the price Ordinary Shares was last bought or sold at on the open market here, on 26 Jun 2023.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Oxford Science Enterprises plc entity
10% owner
$10.20M (1)
—
+$10.20M
16,995,540
$41.47M
+107.3%
M&G INVESTMENT MANAGEMENT LTD entity
10% owner
$1.80M (1)
—
+$1.80M
6,285,946
$15.34M
+206.3%
Wright Robin
Director
$374.31K (3)
—
+$374.31K
0
$0.00
−100.0%
Ellis Christopher
Chief Operating Officer
$1.28K (1)
$309.18K (8) scheduled
−$307.90K
75
$183.00
—
Scheeren Joseph
Director
$126.30K (3)
—
+$126.30K
0
$0.00
—
Griffiths Graham
Chief Business Officer
$1.70K (1)
$116.08K (6)
−$114.38K
104,209
$254.27K
−10.0%
Phillips Anne M.
Director
$51.00K (1)
—
+$51.00K
0
$0.00
—
Enright William
Chief Executive Officer
—
$36.30K (1)
−$36.30K
1,927,683
$4.70M
−29.4%
DAWES KAREN A
Director
$28.90K (1)
—
+$28.90K
0
$0.00
—
Hammacher Alex
Director
$21.14K (2)
—
+$21.14K
0
$0.00
—
Morgon Pierre A.
Director
—
—
—
0
$0.00
−100.0%
Hooftman Leon
Chief Medical Officer
—
—
—
0
$0.00
—
M&G Alternatives Investment Management Ltd entity
10% owner
—
—
—
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Ellis Christopher
25 Aug 2022
Chief Operating Officer
Sold after exercise
25,000
$7.07
$176.71K
Ellis Christopher
25 Aug 2022
Chief Operating Officer
Sold after exercise
14,176
$5.69
$80.69K
Ellis Christopher
24 Aug 2022
Chief Operating Officer
Sold after exercise
450
$4.78
$2.15K
Ellis Christopher
18 Aug 2022
Chief Operating Officer
Sold after exercise
2,175
$4.84
$10.53K
Ellis Christopher
17 Aug 2022
Chief Operating Officer
Sold after exercise
649
$4.77
$3.09K
Ellis Christopher
16 Aug 2022
Chief Operating Officer
Sold after exercise
2,200
$4.78
$10.51K
Ellis Christopher
15 Aug 2022
Chief Operating Officer
Sold after exercise
5,350
$4.76
$25.46K
Ellis Christopher
28 Jun 2022
Chief Operating Officer
Sold after exercise
5
$6.00
$30.00
Griffiths Graham
23 Jun 2022
Chief Business Officer
Sold after exercise
8
$5.28
$42.24
Show all 29 transactions →

What was left out

Form 4 filings counted 87
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 18,984,391
Sales filed before the plan box existed 5
History held since 3 May 2021